Michael S. Cuffe, EVP and Chief Clinical Officer at HCA Healthcare, Inc. (HCA), sold 4,450 shares at $257.11 ($1.0M) on 2023-02-01, disclosed to the SEC on 2023-02-01.
Seasonal sale ($1.0M) by EVP and Chief Clinical Officer — this insider has traded HCA in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 450 | $0 | 0.0% |
| 2 | $257.11 | 4,000 | $1.0M | 100.0% |
| Total | $231.11 avg | 4,450 | $1.0M | 100% |
| Filing → |
| HCA | SELL | 2024-09-12 | $6.4M | — | Filing → |
| HCA | SELL | 2024-05-13 | $4.0M | — | Filing → |
| HCA | SELL | 2024-05-08 | $494K | — | Filing → |